For decades, oto logists, physiologists, and anatomists have studied the mechanism of systemic and ototopical drug uptake by the inner ear. During that time , otologists have searc hed for a safe and effective topical medication to treat otitis externa, otit is med ia, and other otomasto id infections in patients with and witho ut tympanic membrane perforations.
For decades, oto logists, physiologists, and anatomists have studied the mechanism of systemic and ototopical drug uptake by the inner ear. During that time , otologists have searc hed for a safe and effective topical medication to treat otitis externa, otit is med ia, and other otomasto id infections in patients with and witho ut tympanic membrane perforations.
Topical ciprofloxacin has become a widely used medication for treating otitis media in patients with a perforated tympanic memb rane . Its popularity can be attr ibuted to its potency, broad spectrum of coverage, and safety. To the best of our knowledge, intratympanic ciprofloxacin has never been implicated as a cause of ototoxicity.
Still , some quest ions rema in abo ut its absorption. Specific ally:
• Do intratympanic ciprofloxacin drops enter the human inner ear? • Are they absorbed by the systemic circu lation ? • Are they absorbed by the cerebrospina l fluid (CSF)?
A number of animal studies have been performed with various topical antibiotics and other age nts in an attempt to answer questions about absorption of topic al agents.!" The results of some of these studies have been extrapolated to humans, and in many cases they have dicta ted our choice ofdrug dosages, patient management and treatment protocols, informed consent, and laboratory guide lines . In one of these studies, Bagger-Sjoback et al app lied 5 ul of Gelfoam powder mixed wit h O. I mg/ml ofciprofloxacin to the round window membrane (RWM) of I6 chinchi lla ears for a mean of7 5 minutes."After the Ge lfoam was removed, they irrigated the middle ear with sa line and aspirated the labyrinthine fluid by puncturing the RWM with a glass cap illary pipette. The mean level of ciprofloxacin in the inner ear remained co nstant at only O. I 65 ug/ml,
Factors that affe ct RWM permeab ility
Both subst ance and anatomic factors affect RWM permeability.
Substancefactors. Substance factors includ e molecular size and configuration, conc entration, electrical charge , and lipid solubility. Animal studies have also shown that substances with a molecular weight ofless than I,000 (e.g., gentamicin, streptomycin, neomycin, and tetracycline) are transported actively through the RWM over a short period oftime" Substances with a mo lecular weight ofmore than I,000 (e.g., huma n serum albumin, ferritin , and endotoxins) can be transported via pinocytos is. Stero ids have been shown to diffuse through the RWM.
Anatomicfactors. Among the anatomic factors are the thickness ofthe RWM and the presence offalse membranes, tissue plugs, and bony obliteration. In humans, the round window niche has a triangu lar shape and forms a we ll, with the true RWM at the bottom. The RWM separates the niche from the scala tympani . The RWM is thicke st at its edges and thinnest in the center. Its oute r layer is made of epithelium and a continuous basement membrane. The midd le layer contains fibroblasts, collagen, elastic fibers , blood vesse ls, and nerves. The inner layer is mad e up of mesothelium with microp inocytotic vesicles.
In a study of202 temporal bone s in I 17 patients,Alzamil and Linthicum found that the incidence offalse RWMs was 2 I% and the incidence of fat or fibrous plugs was I 1%.7 Of 85 pati ents who underwent examination of bot h ears, 22% had some form of obstruction in both ears ; 56% had no obstruction.
Interspecies differences. Th ere are two primary differences in the RWMs of humans and an ima ls:
• The RWM in animals does not contain the three layers seen in humans." • The RWM in animals is thinner. For example, its thickness is 10 to 14 urn in chinchillas, 20 to 40 urn in cats, and 40 to 60 urn in rhesus monkeys." The thickness of the human RWM ranges from 63 to 67.7 urn.
Huma n labyrinth study
During my time at the Michigan Ear Institute in Farm ington Hills , my senior co lleag ues and I deve loped the Human Labyrinthine Samp ling Mod el (HLSM).Th is mode l allows investigators to accurately determine the intralabyrinthine concentration of syste mic and topica l drugs at diffe rent times following admi nistrati on. Using the HLSM, we were ab le to determine that the human RWM is freely perme-able by gentamicin (inner ear levels ofgentamicin were 16 ug/ml within 30 min) and that intratympanic gentamicin may even be absorbed into the systemic circulation." We also found that intravenous gentamicin was present in the inner ear in significant levels within only a few minutes. With these findings in mind , we then conducted a prospective study to investigate whether intratympanic ciprofloxacin is absorbed through the human RWM. 12We believe th is is the first suc h investigation in living humans. Our study population was made up of 10 patients-6 men and 4 wome n, aged 55 to 73 years (mean : 66)-who were undergoing translabyr inthine aco ustic tumor removal.
During surgery, we instilled 0.5 ml of 0.3% ciprofloxacin ophthalmic solution into eac h ear; 0.1 ml was applied directly to the RWM using a sma ll piece of Gelfoam, and 0.4 ml was injected into the middle ear. Between 9 and 120 minutes later, we opened the lateral semicircular cana l and vestibule and aspirated the labyrinthine fluid with a microsyringe. We also drew serum and CSF sam ples.
The specimens were express-shipped in dry ice to the Mayo Clinic in Rochester, Minn ., for chemical analysis. All samples were then diluted according to standard laboratory practices and analyzed by high-performance liquid chrom atography with fluorescence , which can detect ciprofloxacin levels as low as 0.5 ug/ml . Analysis found no measurable amount ofciprofloxacin absorption in either the labyri nthine fluid or the CSF in any patient. The abse nce of meas urab le ciprofloxacin absorption into the human inner ear, serum, or CSF reinforces its margin of safety.
It should be noted that during middle ear infections, there is often an abundance ofmucosal ede ma, microorganisms, and fluid that might occlu de the round window niche and further inhibit the absorption of ciprofloxacin and other topical medications. Although we made an effort to inspect the RWM in all 10 of our patien ts, this was possible only in 5. There fore, a theoretical poss ibility exists that the lack ofciprofloxac in absorption was the result ofa blockage of the RWM, but we find this highly unlike ly. In our earlier investigation of topica l gentamicin, we noted absorption in nearl y all 13 patients.
The absence ofmeasurable ciprofloxacin absorption into the human inner ear, serum , or CSF in our study illustrates the degree of safety of this drug . It appears to be an appropriate antibiotic for the treatment of otologic disease, even in patients without an intact tympanic membrane.
As for the HLSM , it is a safe , reliab le, easy-to-perform, repeat able , and inexpensive model that provides valuable information. It can thus be used to better unders tand the uptake of medications by the inner ear and to assess the RWM permeability ofclinica lly relevant medications, such as steroi ds and ototopica l ant ibiotics. This model will help us deve lop safer and more effective ways of deliveri ng medica tions to inner ears .
